FLAGSHIP CASE STUDY
Medical-Device Receivables: Government, Hospital, Dealer and Deposit Recovery
A medical device business with 35% of debtors beyond 180 days across hospitals, government procurement bodies and a dealer network. 47% was recovered in six months — a meaningful part of it earnest money deposits and bank guarantees the company no longer held complete records for.
The argument
A device company's receivable is not only its invoices. It is also every deposit and guarantee it has lodged and stopped tracking — money that is owed, uncontested, and unasked for.
Executive summary
A medical device business sells to government and private hospitals, central and state procurement bodies, and a dealer and distributor network. Long payment cycles are structural in the sector — 60, 90, 120 or even 150 days is normal, before any dispute — and insurance reimbursement processes lengthen them further downstream. At engagement, 35% of the debtor book sat beyond 180 days.
- 47% of the overdue book was recovered within six months, with 13% under live follow-up at handover.
- 40% was identified as risk or customer service issue. Not collectable by follow-up: absconded dealers, closed businesses, deceased proprietors, dissolved partnerships and unresolved service claims.
- The recovery included deposits and guarantees the company had stopped tracking. EMDs and bank guarantees lodged against tenders long since concluded, where the client no longer held complete details to claim a refund. Regional teams attended the relevant offices with partial information and reconstructed the position.
- Institutional invoices failed for documentary reasons, not commercial ones. Receipt certificates uncollected across multiple supply locations, LD deductions for delayed supply, unmet expiry norms, missing signatures, bills never uploaded to the portal, and sequential approvals across three departments. Receipt, approval and payment are the buyer's own payables stages; GGA tracked each one to its owner.
- One structural obstacle recurred: expired product blocked portal submission entirely. Where documents had been pending so long that the product's expiry date had passed, the government system would not accept the invoice — requiring direct engagement with departmental finance, procurement and IT teams to agree an exception route.
- Dealer recovery required auditing claims before negotiating them, with expired stock validated at batch level against the sales register before any settlement value was agreed.
The money that stopped being counted
Every tender a device company bids requires money to be lodged. Earnest money deposits at bid stage. Performance and security deposits on award. Bank guarantees held for the duration and beyond. Individually modest; cumulatively, across years of bidding, substantial.
None of it is disputed. The buyer agrees it is repayable. There is no commercial disagreement, no service claim, no question of intent. It simply sits, because the tender concluded, the project team moved on, and nobody retained the paperwork needed to ask for it back.
Why it goes unclaimed
The records are incomplete. The original submission file has been archived or lost across an office move, a system migration or a change of the person who handled the tender. The department that holds the money has itself reorganised. And critically, reclaiming requires attendance — someone physically at the right office with whatever documentation survives, working the question through to a decision.
Partial information is usually enough. On this assignment, regional teams were deployed with the fragments the client still held — tender references, approximate dates, correspondence — and rebuilt enough of the position to enable refund or return. Incomplete records are a reason recovery is slow, not a reason it is impossible.
What the six months produced
| Outcome | Share | What it represents |
|---|---|---|
| Recovered | 47% | Cash and deposit refunds realised within the initial six months. |
| Risk and customer service issues | 40% | No surviving counterparty, or held against an unresolved service claim. Not collectable by follow-up. |
| Under active follow-up | 13% | Live cases with an identified path, carried into the following quarter. |
47% on a book already beyond 180 days is a strong result, and the deposit and guarantee component is part of why. That value was uncontested — the work was locating it and asking, not persuading anyone.
The 40% was reported with a cause attached to each case. Absconded, closed, deceased, dissolved, or held against a specific service failure. That allows provisioning against verified facts, and it identifies which commercial practices produced the disputes in the first place. The reasons were analysed and reported so that future risk and non-payment could be reduced rather than repeated.
What this says for a medical device business
Six conclusions, in order of how much cash they move.
- List every deposit and guarantee you have lodged. Not the ones you can document — all of them, including those where the file is incomplete. It is uncontested money and almost nobody has asked for it. Partial records are enough to start.
- Collect receipt certificates as a despatch discipline, not a collections activity. An invoice that cannot be submitted is not overdue; it does not exist as far as the paying department is concerned. This is the highest-yield fix available on the institutional book.
- Upload before the product expires. A filing delay can take an invoice past the point where the portal will accept it at all. That is money disqualified by administration rather than by dispute.
- Audit expiry claims at batch level before conceding them. Validate against the sales register that the material was sold to that dealer. Unaudited concessions are write-offs wearing a settlement's clothing.
- Contest liquidated damages with the delivery record, promptly. LDs applied for delayed supply are difficult to reverse once settled into the buyer's file, and they are frequently used to hold far more than the deduction itself.
- Verify the dealer before you provision. Two in five rupees here had no surviving counterparty or an unresolved service claim behind them. A field visit settles in an afternoon what a year of calls cannot.
Method and limitations
This study draws on a six-month B2B Revenue Realization assignment for a medical device business in India, covering government and private hospitals, central and state procurement bodies, and a dealer and distributor network. The assignment was extended on a rolling basis, with overdue beyond 90 days transferring to GGA thereafter.
The outcome percentages are as reported at the close of the initial six months and describe the overdue book at handover. They record one assignment and are not a general recovery rate.
The 60 to 150 day payment range is a sector characteristic reported by the client and consistent with GGA's work across medical devices and adjacent healthcare businesses. It is not a measured statistic from this book.
The causal material is field observation from customer, dealer and departmental visits rather than measurement, offered as pattern rather than statistics.
No invoice-level dataset underpins this study. Where a study in this series rests on line-item data, that is stated explicitly; here it does not.
No individual debtor is identified. GGA does not publish the payment behaviour of any named company.
Evidence boundary
This is historical evidence from one GGA engagement. It explains the starting position, operating mechanism and measured outcome on the stated denominator. It is not a universal benchmark, forecast or recovery guarantee for another portfolio.
Percentages from different denominators or measurement dates are not combined.